SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $22,000 | +22.2% | 700 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $18,000 | -97.8% | 700 | -97.8% | 0.00% | -97.9% |
| Q4 2020 | $807,000 | +2.4% | 32,068 | -15.2% | 0.05% | +14.6% |
| Q3 2020 | $788,000 | -12.2% | 37,798 | -0.0% | 0.04% | -16.3% |
| Q2 2020 | $898,000 | +109.3% | 37,808 | +141.9% | 0.05% | +226.7% |
| Q3 2019 | $429,000 | -19.1% | 15,627 | -2.5% | 0.02% | -16.7% |
| Q2 2019 | $530,000 | -7.5% | 16,027 | -2.1% | 0.02% | -5.3% |
| Q1 2019 | $573,000 | +4.0% | 16,366 | -1.3% | 0.02% | 0.0% |
| Q4 2018 | $551,000 | -34.0% | 16,577 | -0.0% | 0.02% | -20.8% |
| Q3 2018 | $835,000 | -76.6% | 16,581 | -72.1% | 0.02% | -76.7% |
| Q2 2018 | $3,562,000 | +35.1% | 59,521 | +3.4% | 0.10% | +18.4% |
| Q1 2018 | $2,637,000 | +45.2% | 57,571 | +26.4% | 0.09% | +52.6% |
| Q4 2017 | $1,816,000 | -26.0% | 45,562 | -25.8% | 0.06% | -30.5% |
| Q3 2017 | $2,455,000 | -21.0% | 61,367 | -14.9% | 0.08% | -13.7% |
| Q2 2017 | $3,109,000 | -22.7% | 72,129 | -43.9% | 0.10% | -18.1% |
| Q1 2017 | $4,023,000 | +20.7% | 128,520 | -2.6% | 0.12% | +18.4% |
| Q4 2016 | $3,332,000 | -26.3% | 131,971 | -27.8% | 0.10% | -26.3% |
| Q3 2016 | $4,520,000 | +9.0% | 182,791 | -10.2% | 0.13% | +7.3% |
| Q2 2016 | $4,148,000 | +16.5% | 203,613 | -12.8% | 0.12% | +17.0% |
| Q1 2016 | $3,562,000 | +22162.5% | 233,592 | +19173.3% | 0.11% | – |
| Q4 2015 | $16,000 | – | 1,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |